Long-term Eculizumab Therapy in a Child With Refractory Immune Complex–Mediated Membranoproliferative Glomerulonephritis
Rahul Chanchlani(McMaster Children's Hospital), Christoph Licht(University of Toronto), Paul S. Thorner(University of Toronto), Michael Kirschfink(Heidelberg University), Diane Hébert(University of Toronto), Valérie S. Langlois(Institut National de la Recherche Scientifique), Daniel C. Cattran(Toronto Rehabilitation Institute), Seetha Radhakrishnan(University of Toronto), Steven Arora(McMaster Children's Hospital), David Barth(University Health Network)
Cited by 3
Related Papers
Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test
|Genetics in Medicine|2017|563
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
|Kidney International|2011|361
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach
|Kidney International|2013|350
ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption
|Journal of Clinical Investigation|2013|341